cdr3.alpha	v.alpha	j.alpha	cdr3.beta	v.beta	d.beta	j.beta	species	mhc.a	mhc.b	mhc.class	antigen.epitope	antigen.gene	antigen.species	reference.id	submitter	method.identification	method.frequency	method.singlecell	method.sequencing	method.verification	meta.study.id	meta.cell.subset	meta.subset.frequency	meta.subject.cohort	meta.subject.id	meta.replica.id	meta.clone.id	meta.epitope.id	meta.tissue	meta.donor.MHC	meta.donor.MHC.method	meta.structure.id	comment	v.alpha.fixed	j.alpha.fixed	v.beta.fixed	j.beta.fixed	v.alpha.end.fixed	j.alpha.start.fixed	v.beta.end.fixed	j.beta.start.fixed	v.alpha.end.old	j.alpha.start.old	v.beta.end.old	j.beta.start.old
			CSARDRIGNGYTFG	TRBV20-1		TRBJ1-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA1				synovial fluid				number of baterial clones supporing the CDR3 10/12, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CSARDGTGNGYTFG	TRBV20-1		TRBJ1-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL1				PBMC				number of baterial clones supporing the CDR3 25/31, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CSARDRTGNGYTFG	TRBV20-1		TRBJ1-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL1				PBMC				number of baterial clones supporing the CDR3 6/31, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CSARSGVGNTIYFG	TRBV20-1		TRBJ1-3	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL1				PBMC				number of baterial clones supporing the CDR3 11/11, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	12	12	-1	-1	12	14
			CSVGSTGGTNEKLFFG	TRBV29-1		TRBJ1-4	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL1				PBMC				number of baterial clones supporing the CDR3 11/26, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV29-1*01	TRBJ1-1*01	-1	-1	10	14	-1	-1	7	16
			CSVGSAGTNEKLFFG	TRBV29-1		TRBJ1-4	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL1				PBMC				number of baterial clones supporing the CDR3 2/26, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV29-1*01	TRBJ1-1*01	-1	-1	10	13	-1	-1	7	15
			CSVREDSTNEKLFFG	TRBV29-1		TRBJ1-4	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL1				PBMC				number of baterial clones supporing the CDR3 1/26, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV29-1*01	TRBJ1-1*01	-1	-1	9	13	-1	-1	7	15
			CASSQSPGGIQYFG	TRBV14		TRBJ2-4	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL1				PBMC				number of baterial clones supporing the CDR3 12/12, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV16*01	TRBJ1-1*01	-1	-1	17	12	-1	-1	12	14
			CASSTGQVSPGELFFG	TRBV2		TRBJ2-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL1				PBMC				number of baterial clones supporing the CDR3 2/19, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV15*01	TRBJ1-1*01	-1	-1	13	14	-1	-1	12	16
			CASSEGRVSPGELFFG	TRBV2		TRBJ2-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL1				PBMC				number of baterial clones supporing the CDR3 5/19, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV2*01	TRBJ1-1*01	-1	-1	16	14	-1	-1	15	16
			CASSEGRISPGELFFG	TRBV2		TRBJ2-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL1				PBMC				number of baterial clones supporing the CDR3 11/19, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV2*01	TRBJ1-1*01	-1	-1	16	14	-1	-1	15	16
			CASSEGNVAPGELFFG	TRBV2		TRBJ2-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL1				PBMC				number of baterial clones supporing the CDR3 1/19, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV2*01	TRBJ1-1*01	-1	-1	16	14	-1	-1	15	16
			CSARSGTGGDYTFG	TRBV20-1		TRBJ1-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL2				PBMC				number of baterial clones supporing the CDR3 15/19, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	12	12	-1	-1	12	14
			CSARDSTGNGYTFG	TRBV20-1		TRBJ1-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL2				PBMC				number of baterial clones supporing the CDR3 1/19, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CSARDRTGNGYTFG	TRBV20-1		TRBJ1-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL2				PBMC				number of baterial clones supporing the CDR3 1/19, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CSARDGTGNGYTFG	TRBV20-1		TRBJ1-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL2				PBMC				number of baterial clones supporing the CDR3 2/19, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CASSSGLVAPGELFFG	TRBV2		TRBJ2-1	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL2				PBMC				number of baterial clones supporing the CDR3 1/1, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV15*01	TRBJ1-1*01	-1	-1	16	14	-1	-1	12	16
			CSVGTATNEKLFFG	TRBV29-1		TRBJ1-4	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL3				PBMC				number of baterial clones supporing the CDR3 14/14, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV29-1*01	TRBJ1-1*01	-1	-1	10	12	-1	-1	7	14
			CASSQSPGGTQYFG	TRBV14		TRBJ2-3	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL3				PBMC				number of baterial clones supporing the CDR3 12/14, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV16*01	TRBJ1-1*01	-1	-1	17	12	-1	-1	12	14
			CASSQSPGGTQYFG	TRBV14		TRBJ2-5	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL3				PBMC				number of baterial clones supporing the CDR3 2/14, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV16*01	TRBJ1-1*01	-1	-1	17	12	-1	-1	12	14
CAEYSSASKIIFG	TRAV5	TRAJ3					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL3				PBMC				number of baterial clones supporing the CDR3 21/21, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV13-2*01	TRAJ4*01	NA	NA	9	10	-1	-1	9	13	-1	-1
			CSARDGTGNGYTFG	TRBV20-1		TRBJ1-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL4				PBMC				number of baterial clones supporing the CDR3 26/29, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CSARDRTGNGYTFG	TRBV20-1		TRBJ1-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL4				PBMC				number of baterial clones supporing the CDR3 2/29, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CSARDWTGNGYTFG	TRBV20-1		TRBJ1-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL4				PBMC				number of baterial clones supporing the CDR3 1/29, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CASSQSPGGFQYFG	TRBV14		TRBJ2-3	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL4				PBMC				number of baterial clones supporing the CDR3 19/19, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV16*01	TRBJ1-1*01	-1	-1	17	12	-1	-1	12	14
			CASSDGAILPGELFFG	TRBV2		TRBJ2-1	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL4				PBMC				number of baterial clones supporing the CDR3 21/21, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV24-1*01	TRBJ1-1*01	-1	-1	15	14	-1	-1	14	16
CAENSNTGNQFYFG	TRAV5	TRAJ49					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		healthy, EBV-seropositive	PBL4				PBMC				number of baterial clones supporing the CDR3 36/36, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV13-2*01	TRAJ4*01	NA	NA	13	11	-1	-1	10	14	-1	-1
			CSARDATGNGYTFG	TRBV20-1		TRBJ1-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA1				synovial fluid				number of baterial clones supporing the CDR3 1/12, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CSARDQTGNGYTFG	TRBV20-1		TRBJ1-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA1				synovial fluid				number of baterial clones supporing the CDR3 1/12, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CSARDEVGNTIYFG	TRBV20-1		TRBJ1-3	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA1				synovial fluid				number of baterial clones supporing the CDR3 18/18, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CSVGTGGTNEKLFFG	TRBV29-1		TRBJ1-4	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA1				synovial fluid				number of baterial clones supporing the CDR3 28/30, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV29-1*01	TRBJ1-1*01	-1	-1	10	13	-1	-1	7	15
			CSVGSGGTNEKLFFG	TRBV29-1		TRBJ1-4	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA1				synovial fluid				number of baterial clones supporing the CDR3 2/30, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV29-1*01	TRBJ1-1*01	-1	-1	10	13	-1	-1	7	15
			CASTSGQLAPGELFFG	TRBV2		TRBJ2-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA1				synovial fluid				number of baterial clones supporing the CDR3 18/18, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV7-9*05	TRBJ1-1*01	-1	-1	13	14	-1	-1	10	16
CAESIGKLIFG	TRAV5	TRAJ23					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA1				synovial fluid				number of baterial clones supporing the CDR3 29/29, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV5*01	TRAJ4*01	NA	NA	13	8	-1	-1	13	9	-1	-1
			CSARDRVGNTIYFG	TRBV20-1		TRBJ1-3	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA11				synovial fluid				number of baterial clones supporing the CDR3 20/21, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	14	12	-1	-1	12	14
			CSARLGVGNTIYFG	TRBV20-1		TRBJ1-3	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA11				synovial fluid				number of baterial clones supporing the CDR3 1/21, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	12	12	-1	-1	12	14
			CSVGTGGTNEKLFFG	TRBV29-1		TRBJ1-4	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA11				synovial fluid				number of baterial clones supporing the CDR3 36/36, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV29-1*01	TRBJ1-1*01	-1	-1	10	13	-1	-1	7	15
CAEDQNARLMFG	TRAV5	TRAJ31					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA11				synovial fluid				number of baterial clones supporing the CDR3 10/17, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV13-2*01	TRAJ4*01	NA	NA	9	9	-1	-1	9	12	-1	-1
CAEDQNAKLMFG	TRAV5	TRAJ31					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA11				synovial fluid				number of baterial clones supporing the CDR3 7/17, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV13-2*01	TRAJ4*01	NA	NA	9	9	-1	-1	9	12	-1	-1
CAESIGKLIFG	TRAV5	TRAJ34					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA11				synovial fluid				number of baterial clones supporing the CDR3 30/30, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV5*01	TRAJ4*01	NA	NA	13	8	-1	-1	13	10	-1	-1
			CSVGTGGTNEKLFFG	TRBV29-1		TRBJ1-4	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA14				synovial fluid				number of baterial clones supporing the CDR3 30/30, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV29-1*01	TRBJ1-1*01	-1	-1	10	13	-1	-1	7	15
CAESTGKLIFG	TRAV5	TRAJ37					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA14				synovial fluid				number of baterial clones supporing the CDR3 23/23, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV5*01	TRAJ4*01	NA	NA	13	8	-1	-1	13	9	-1	-1
			CSARLGVGNTIYFG	TRBV20-1		TRBJ1-3	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA15				synovial fluid				number of baterial clones supporing the CDR3 33/33, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	12	12	-1	-1	12	14
CAEDLNARLMFG	TRAV5	TRAJ31					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA15				synovial fluid				number of baterial clones supporing the CDR3 24/24, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV13-2*01	TRAJ4*01	NA	NA	9	9	-1	-1	9	12	-1	-1
			CSAPGQEISTEAFFG	TRBV20-1		TRBJ1-1	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA2				synovial fluid				number of baterial clones supporing the CDR3 10/10, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	9	13	-1	-1	9	13
			CSVGSSGTNEKLFFG	TRBV29-1		TRBJ1-4	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA2				synovial fluid				number of baterial clones supporing the CDR3 29/29, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV29-1*01	TRBJ1-1*01	-1	-1	10	13	-1	-1	7	15
			CASSQSPGGTQYFG	TRBV14		TRBJ2-3	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA2				synovial fluid				number of baterial clones supporing the CDR3 27/27, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV16*01	TRBJ1-1*01	-1	-1	17	12	-1	-1	12	14
CAERRETDKLIFG	TRAV5	TRAJ34					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA2				synovial fluid				number of baterial clones supporing the CDR3 19/19, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV5*01	TRAJ4*01	NA	NA	13	10	-1	-1	13	12	-1	-1
CAESSSRGKLIFG	TRAV5	TRAJ37					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA2				synovial fluid				number of baterial clones supporing the CDR3 27/27, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV5*01	TRAJ4*01	NA	NA	13	10	-1	-1	13	11	-1	-1
CAEYSSASKIIFG	TRAV5	TRAJ3					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA2				synovial fluid				number of baterial clones supporing the CDR3 15/15, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV13-2*01	TRAJ4*01	NA	NA	9	10	-1	-1	9	13	-1	-1
			CSARIGVGNTIYFG	TRBV20-1		TRBJ1-3	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA3				synovial fluid				number of baterial clones supporing the CDR3 24/24, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	12	12	-1	-1	12	14
			CSVGMDGVTNEKLFFG	TRBV29-1		TRBJ1-4	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA3				synovial fluid				number of baterial clones supporing the CDR3 21/23, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV29-1*01	TRBJ1-1*01	-1	-1	10	14	-1	-1	7	16
			CASTSGQTFPGELFFG	TRBV2		TRBJ2-2	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA3				synovial fluid				number of baterial clones supporing the CDR3 14/14, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV7-9*05	TRBJ1-1*01	-1	-1	13	14	-1	-1	10	16
CAEDAASTLTFG	TRAV5	TRAJ11					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA3				synovial fluid				number of baterial clones supporing the CDR3 5/5, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV13-2*01	TRAJ4*01	NA	NA	9	9	-1	-1	9	10	-1	-1
CAESSGSQGNLIFG	TRAV5	TRAJ42					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA3				synovial fluid				number of baterial clones supporing the CDR3 3/3, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV5*01	TRAJ4*01	NA	NA	13	11	-1	-1	13	12	-1	-1
			CASSQSPGGTQYFG	TRBV14		TRBJ2-3	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA4				synovial fluid				number of baterial clones supporing the CDR3 3/8, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV16*01	TRBJ1-1*01	-1	-1	17	12	-1	-1	12	14
			CASSQSPGGTQYFG	TRBV14		TRBJ2-5	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA4				synovial fluid				number of baterial clones supporing the CDR3 5/8, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV16*01	TRBJ1-1*01	-1	-1	17	12	-1	-1	12	14
CAEYSSASKIIFG	TRAV5	TRAJ3					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA4				synovial fluid				number of baterial clones supporing the CDR3 12/12, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV13-2*01	TRAJ4*01	NA	NA	9	10	-1	-1	9	13	-1	-1
			CSARAGVGNTIYFG	TRBV20-1		TRBJ1-3	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA5				synovial fluid				number of baterial clones supporing the CDR3 13/13, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV20-1*01	TRBJ1-1*01	-1	-1	13	12	-1	-1	12	14
			CSVGSGGTNEKLFFG	TRBV29-1		TRBJ1-4	HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA5				synovial fluid				number of baterial clones supporing the CDR3 12/26, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	NA	NA	TRBV29-1*01	TRBJ1-1*01	-1	-1	10	13	-1	-1	7	15
CAEDADSTLTFG	TRAV5	TRAJ11					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA5				synovial fluid				number of baterial clones supporing the CDR3 20/20, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV13-2*01	TRAJ4*01	NA	NA	9	9	-1	-1	9	10	-1	-1
CAESTGKLIFG	TRAV5	TRAJ37					HomoSapiens	HLA-A*02	B2M	MHCI	GLCTLVAML	BMLF1	EBV	PMID:10925283	Ivan Zvyagin	MHC-peptide-beads,cultivated-t-cells			sanger	tetramer-sort,antigen-loaded-targets		CD8		rheumatoid arthritis, previously documented reactivity against EBV	RA5				synovial fluid				number of baterial clones supporing the CDR3 16/16, MHC-peptide-beads = avidin-coated beads with MHC-peptide monomers	TRAV5*01	TRAJ4*01	NA	NA	13	8	-1	-1	13	9	-1	-1
